Abortion Pills May Be FDA’s First Test Under Trump

“While the early focus on a Trump administration Food and Drug Administration has been on vaccine policy, one of its first moves could be overhauling the federal rules that have made it easier to access the widely used abortion pill mifepristone,” Axios reports.

“Use of the drug has surged as states enacted near or total abortion bans after Roe v. Wade was overturned in 2022. But new agency leadership could quickly move to roll back some of the policies that were the focus of a closely watched Supreme Court case this year.”